Nasal mucociliary clearance as a factor in nasal drug delivery

Advanced Drug Delivery Reviews

Volumn 29, Issue 1-2, 1998, Pages 13-38

  Marttin, Emmeline ^a   Schipper, Nicolaas G M ^a   Coos Verhoef, J ^a   Merkus, Frans W H M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Absorption enhancers; Ciliary beat frequency; Cyclodextrins; Nasal drug delivery; Nasal mucocialiary clearance; Preservatives

Indexed keywords

ABSORPTION; PHARMACOKINETICS; POLYSACCHARIDES; TRANSPORT PROPERTIES;

CILIARY BEAT FREQUENCY; CYCLODEXTRIN; NASAL MUCOCILIARY CLEARANCE SYSTEM;

CONTROLLED DRUG DELIVERY;

CYCLODEXTRIN; DRUG;

CILIATED EPITHELIUM; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; MUCOCILIARY CLEARANCE; NASOPHARYNX; NOSE CAVITY; NOSE MUCOSA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; UPPER RESPIRATORY TRACT;

EID: 0032484634     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00059-8     Document Type: Review

References (254)

1. Hosoya K.I., Kubo H., Natsume H., Sugibayashi K., Morimoto Y., Yamashita S. The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits. Biopharm. Drug Dispos. 14:1993;685-696.
2. Fisher A.N., Illum L., Davis S.S., Schacht E.H. Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat. J. Pharm. Pharmacol. 44:1992;550-554.
3. McMartin C., Hutchinson L.E.F., Hyde R., Peters G.E. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pharm. Sci. 76:1987;535-540.
4. Schipper N.G.M., Verhoef J., Merkus F.W.H.M. The nasal mucociliary clearance: Relevance to nasal drug delivery. Pharm. Res. 8:1991;807-814.
5. Monteiro-Riviere N.A., Popp J.A. Ultrastructural characterization of the nasal respiratory epithelium in the rat. Am. J. Anat. 169:1984;31-43.
6. Satir P. The generation of ciliary motion. J. Protozool. 31:1984;8-12.
7. Satir P., Sleigh M.A. The physiology of cilia and mucociliary interactions. Annu. Rev. Physiol. 52:1990;137-155.
8. B.A. Afzelius, Ciliary dysfunction, in: R.G. Crystal, J.B. West (Eds.), The lung: Scientific Foundations, Lippincott-Raven, Philadelphia, 1997, pp. 2573-2578.
9. Summers K.E., Gibbons I.R. Adenosine triphosphate-induced sliding of tubules in trypsin-treated flagella of sea-urchin sperm. Proc. Natl. Acad. Sci. U.S.A. 68:1971;3092-3096.
10. Satir P. Studies on cilia. 3. Further studies on the cilium tip and a "sliding filament" model of ciliary motility. J. Cell Biol. 39:1968;77-94.
11. Batts Lansley A. Mucociliary clearance and drug delivery via the respiratory tract. Adv. Drug Deliv. Rev. 11:1993;299-327.
12. Wanner A. Clinical aspects of mucociliary transport. Am. Rev. Respir. Dis. 116:1977;73-125.
13. Clary-Meinesz C.F., Cosson J., Huitorel P., Blaive B. Temperature effect on the ciliary beat frequency of human nasal and tracheal ciliated cells. Biol. Cell. 76:1992;335-338.
14. Sleigh M.A., Blake J.R., Liron N. The propulsion of mucus by cilia. Am. Rev. Respir. Dis. 137:1988;726-741.
15. Green A., Smallman L.A., Logan A.C.M., Drake-Lee A.B. The effect of temperature on nasal ciliary beat frequency. Clin. Otolaryngol. 20:1995;178-180.
16. Girard P.R., Kennedy J.R. Calcium regulation of ciliary activity in rabbit tracheal epithelial explants and outgrowth. Eur. J. Cell Biol. 40:1996;203-209.
17. 2+](i) and ciliary beating in cultured tracheal epithelial cells. J. Cell Sci. 108:1995;431-440.
18. Sanderson M.J., Dirksen E.R. Mechanosensitivity of cultured ciliated cells from the mammalian respiratory tract: implications for the regulation of mucociliary transport. Proc. Natl. Acad. Sci. U.S.A. 86:1986;7302-7306.
19. Sanderson M.J., Chow I., Dirksen E.R. Intercellular communication between ciliated cells in culture. Am. J. Physiol. Cell Physiol. 254:1988;C63-C74.
20. 2+]. Biophys. J. 56:1989;1255-1258.
21. Sanderson M.J., Dirksen E.R. Mechanosensitive and beta-adrenergic control of the ciliary beat frequency of mammalian respiratory tract cells in culture. Am. Rev. Respir. Dis. 139:1989;432-440.
22. Sanderson M.J., Lansley A.B., Dirksen E.R. Regulation of ciliary beat frequency in respiratory tract cells. Chest. 101:1992;69S-71S.
23. 2+ and cAMP. Am. J. Physiol. 263:1992;L232-L242.
24. 2+. J. Cell Biol. 111:1990;170a.
25. Geary C.A., Davis C.W., Paradiso A.M., Boucher R.C. Role of CNP in human airways: cGMP mediated stimulation of ciliary beat frequency. Am. J. Physiol. Lung Cell. Mol. Physiol. 268:1995;L1021-L1028.
26. Sisson J.H. Ethanol stimulates apparent nitric oxide-dependent ciliary beat frequency in bovine airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 12:1995;L596-L600.
27. Rosbe K.W., Mims J.W., Prazma J., Petrusz P., Rose A., Drake A.F. Immunohistochemical localization of nitric oxide synthase activity in upper respiratory epithelium. Laryngoscope. 106:1996;1075-1079.
28. Lindberg S., Cervin A., Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol. 117:1997;113-117.
29. Widdicombe J.H. Fluid transport across airway epithelia. Ciba Found. Symp. 109:1984;109-120.
30. Sanderson M.J., Sleigh M.A. Ciliary activity of cultured rabbit tracheal epithelium: beat pattern and metachrony. J. Cell Sci. 47:1981;331-347.
31. Verdugo P. Goblet cells secretion and mucogenesis. Annu. Rev. Physiol. 52:1990;157-176.
32. Roussel P., Lamblin G., Lhermitte M., Houdret N., Lafitte J.J., Perini J.M., Klein A., Scharfman A. The complexity of mucins. Biochimie. 70:1988;1471-1482.
33. Porchet N., Dufosse J., Audie J.P., Duperat V.G., Perini J.M., Nguyen V.C., Degand P., Aubert J.P. Structural features of the core proteins of human airway mucins ascertained by cDNA cloning. Am. Rev. Respir. Dis. 144:1991;S15-S18.
34. Lethem M.I. The role of tracheobronchial mucus in drug administration to the airways. Adv. Drug Deliv. Rev. 11:1993;19-27.
35. Gelman R.A., Meyer F.A. Mucociliary transference rate and mucus viscoelasticity dependence on dynamic storage and loss modulus. Am. Rev. Respir. Dis. 120:1979;553-557.
36. Chen T.M., Dulfano M.J. Mucus viscoelasticity and mucociliary transport rate. J. Lab. Clin. Med. 91:1978;423-431.
37. Andersen I., Proctor D.F. Measurement of nasal mucociliary clearance. Eur. J. Respir. Dis. 64:1983;37-40.
38. Corbo G.M., Foresi A., Bonfitto P., Mugnano A., Agabiti N., Cole P.J. Measurement of nasal mucociliary clearance. Arch. Dis. Child. 64:1989;546-550.
39. Van Ree J.H.L., Van Dishoeck H.A.E. Some investigations on nasal ciliary activity. Pract. Otorhinolaryngol. 24:1962;383-390.
40. Kao C.H., Jiang R.S., Wang S.J., Yeh S.H. Influence of age, gender, and ethnicity on nasal mucociliary clearance function. J. Nucl. Med. 19:1994;813-816.
41. Middleton P.G., Geddes D.M., Alton E.F.W.W. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects. Thorax. 48:1993;812-816.
42. Lioté H., Zahm J., Pierrot D., Puchelle E. Role of mucus and cilia in nasal mucociliary clearance in healthy subjects. Am. Rev. Respir. Dis. 140:1989;132-136.
43. Lindberg S. Morphological and functional studies of the mucociliary system during infections in the upper airways. Acta Otolaryngol. Suppl. 515:1994;22-25.
44. Rautiainen M., Nuutinen J., Kiukaannienii H., Collan Y. Ultrastructural changes in human nasal cilia caused by the common cold and recovery of ciliated epithelium. Ann. Otol. Rhinol. Laryngol. 101:1992;982-987.
45. Konrad F., Schreiber T., Brecht-Kraus D., Georgieff M. Mucociliary transport in ICU patients. Chest. 105:1994;237-241.
46. Sachdeva A., Sachdeva O.P., Gulatie S.P., Kakkar V. Nasal mucociliary clearance and mucus pH in patient with diabetes mellitus. Ind. J. Med. Res. 98:1993;265-268.
47. Camner P. Minireview: How important is mucociliary clearance? Exp. Lung Res. 14:1988;423-429.
48. Newhouse T. Primary ciliary dyskinesia. What has it taught us about pulmonary disease? Eur. J. Respir. Dis. Suppl. 127:1983;151-156.
49. Mossberg B., Afzelius B., Camner P. Mucociliary clearance in obstructive lung diseases. Correlations to the immotile cilia syndrome. Eur. J. Respir. Dis. Suppl. 146:1986;295-301.
50. Ohashi Y., Nakai Y., Ikeoka H., Furuya H. Regeneration of nasal mucosa following mechanical injury. Acta Otolaryngol. Suppl. 486:1991;193-201.
51. Zhou M., Donovan M. Recovery of the nasal mucosa following laureth-9 induced damage. Int. J. Pharm. 130:1996;93-102.
52. Van de Donk H.J.M., Zuidema J., Merkus F.W.H.M. The influence of pH and osmotic pressure upon tracheal ciliary beat frequency as determined with a new photoelectric registration device. Rhinology. 18:1980;93-104.
53. Ganbo T., Hisamatsu K., Mizukoshi A., Inoue H., Kikushima K., Kou J., Kozuka Y., Murakami Y. Effect of ibudilast on ciliary activity of human paranasal sinus mucosa in vitro. Arzneim.-Forsch. Drug Res. 45:1995;883-886.
54. Gilain L., Zahm J.M., Pierrot D., Fuchey C., Peynegre R., Puchelle E. Nasal epithelial cell culture as a tool in evaluating ciliary dysfunction. Acta Otolaryngol. 113:1993;772-776.
55. Sisson J.H., Yonkers A.J., Waldman R.H. Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers. Chest. 107:1995;747-751.
56. Gyi A., Ocallaghan C., Langton J.A. Effect of halothane on cilia beat frequency of ciliated human respiratory epithelium in vitro. Br. J. Anaesth. 73:1994;507-510.
57. Raphael J.H., Strupish J., Selwyn D.A., Hann H.C.L., Langton J.A. Recovery of respiratory ciliary function after depression by inhalation anaesthetic agents: an in vitro study using nasal turbinate explants. Br. J. Anaesth. 76:1996;845-859.
58. Selwyn D.A., Gyi A., Raphael J.H., Key A., Langton J.A. A perfusion system for in vitro measurement of human cilia beat frequency. Br. J. Anaesth. 76:1996;111-115.
59. Curtis L.N., Carson J.L. Computer-assisted video measurement of inhibition of ciliary beat frequency of human nasal epithelium in vitro by xylometazoline. J. Pharm. Toxicol. Methods. 28:1992;1-7.
60. Selwyn D.A., Raphael J.H., Lambert D.G., Langton J.A. Effects of morphine on human nasal cilia beat frequency in vitro. Br. J. Anaesth. 76:1996;274-277.
61. Sanderson M.J., Dirksen E.R. Quantification of ciliary beat frequency and metachrony by high-speed digital video. Methods Cell Biol. 47:1995;289-297.
62. Yoshitsugu M., Rautiainen M., Matsune S., Nuutinen J., Ohyama M. Effect of erogenous ATP on ciliary beat of human ciliated cells studied with differential interference microscope equipped with high speed video. Acta Otolaryngol. 113:1993;655-659.
63. Rautiainen M., Matsuen S., Shima S., Sakamoto K., Hanamure Y., Ohyama M. Ciliary beat of cultured human respiratory cells studied with differential interference microscope and high speed video system. Acta Otolaryngol. 112:1992;845-851.
64. Sanderson M.J., Charles A.C., Dirksen E.R. Measurement of the temperospatial dynamics of intercellular calcium signalling with digital fluorescence microscopy. Am. Lab. 25:1993;29-36.
65. Mercke U., Håkansson C.H., Toremaln N.G. A method for standardized studies of mucociliary activity. Acta Otolaryngol. 78:1974;118-123.
66. Hybbinette J.C., Mercke U. A method for evaluating the effect of pharmacological substances on mucociliary activity in vivo. Acta Otolaryngol. 93:1982;151-159.
67. Lee W.I., Verdugo P. Ciliary activity by laser light scattering spectroscopy. J. Appl. Physiol. Ann. Biomed. Eng. 5:1977;248-259.
68. Wong L.B., Miller I.F., Yeates D.B. Stimulation of ciliary beat frequency by autonomic agonists: in vivo. J. Appl. Physiol. 65:1988;971-981.
69. Wong L.B., Miller I.F., Yeates D.B. Nature of the mammalian ciliary metachronal wave (special communication). J. Appl. Physiol. 75:1993;458-467.
70. Dalhanm T., Rylander R. Frequency of ciliary beat measured with a photo-sensitive cell. Nature. 196:1962;592-593.
71. Stanley P.J., Griffin W.M., Wilson R., Greenstrone M.A., Mackay I.S., Cole P.J. Effect of betamethasone and betamethasone with neomycin nasal drops on human nasal mucociliary clearance and ciliary beat frequency. Thorax. 40:1985;607-612.
72. Ingels K.J.A.O., Nijziel M.R., Graamans K., Huizing E.H. Influence of cocaine and lidocaine on human nasal cilia. Arch. Otolaryngol. 120:1994;197-201.
73. Schuil P.J., Graamans K., Huizing E.H. Cell suspension cultures and adenoid epithelium: an assessment of the source of material for human ciliary function experiments in vitro. Rhinology. 33:1995;66-69.
74. Raphael J.H., Selwyn D.A., Mottram S.D., Langton J.A., Ocallaghan C.O. Effects of 3 MAC of halothane, enflurane and isoflurane on cilia beat frequency of human nasal epithelium in vitro. Br. J. Anaesth. 76:1996;116-121.
75. Kanthakumar K., Cundell D.R., Hohnson M., Wills P.J., Taylor G.W., Cole P.J., Wilson R. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br. J. Pharmacol. 112:1994;193-498.
76. Yager J., Chen T.M., Dulfano M.J. Measurement of frequency of ciliary beats of human respiratory epithelium. Chest. 73:1978;627-633.
77. Eshel D., Grossman Y., Priel Z. Spectral characterization of ciliary beating: Variations of frequency with time. Am. J. Physiol. 249:1985;C160-C165.
78. Braga P.C., Oglio G.D., Bossi R., Allegra L. Simple and precise method for counting ciliary beats directly from the TV monitor screen. Am. J. Physiol. Cell Physiol. 249:1986;C160-C165.
79. Teichtahl H., Wright P.L., Kirsner R.L.G. Measurement of in vitro ciliary beat frequency: a television-video modification of the transmitted light technique. Med. Biol. Engin. Comput. 24:1986;193-196.
80. Van de Donk H.J.M., Zuidema J., Merkus F.W.H.M. Correlation between the sensitivity of the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs. Rhinology. 20:1982;81-87.
81. Joki S., Saano V., Nuutinen J., Virta P., Karttunen P., Silvasti M., Toskala E. Effects of some preservative agents on rat and guinea pig tracheal and human nasal ciliary beat frequency. Am. J. Rhinol. 10:1996;181-186.
82. Coles P., Griffin W. Effect of topical nasal medications on human nasal ciliary function. Eur. J. Respir. Dis. 126:1983;121-122.
83. Deitmer T., Scheffler R. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro. Rhinology. 31:1993;151-153.
84. Ingels K.J.A.O., Kortmann M.J.W., Nijziel M.R., Graamans K., Huizing E.H. Factors influencing ciliary beat measurements. Rhinology. 29:1991;17-26.
85. Van de Donk H.J.M., Zuidema J., Merkus F.W.H.M. The effects of nasal drops on the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs. Rhinology. 19:1981;215-230.
86. Hermens W.A.J.J., Hooymans P.M., Verhoef J.C., Merkus F.W.H.M. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro. Pharm. Res. 7:1990;144-146.
87. Yang B., McCaffrey T.V., Kern E.B. Cryopreservation of human nasal ciliated epithelium. Am. J. Rhinol. 10:1996;291-297.
88. W.M. Boek, S.G. Romeijn, J.C. Verhoef, F.W.H.M. Merkus, K. Graamans, E.H. Huizing, Effect of nasal drug excipients on ciliary beat frequency: comparison of chicken trachea and cryopreserved human sphenoidal sinus mucosa. International Congress on Cilia, Mucus and Mucociliary Interactions, Jerusalem, 23-28 February, 1997, Abstracts, 16.
89. Jian L., Li Wan Po A. Effect of xylometazoline and antazoline on ciliary beat frequency. Int. J. Pharm. 86:1992;59-67.
90. Su X., Li W.P., Millership J.S. Ciliotoxicity of intranasal formulations: menthol enantiomers. Chirality. 5:1993;58-60.
91. Jian L., Li Wan Po A. Effects of insulin and nasal absorption enhancers on ciliary activity. Int. J. Pharma. 95:1993;101-104.
92. Jian L., Li Wan Po A. Kinetic evaluation of the ciliotoxicity of methyl- and propyl-p-hydroxybenzoates using factorial experiments. J. Pharm. Pharmacol. 45:1993;98-101.
93. Jian L., Li Wan Po A. Ciliotoxicity of methyl- and propyl-p-hydroxybenzoates: a dose-response and surface response study. J. Pharm. Pharmacol. 45:1993;925-927.
94. Su X.Y., Li Wan Po A. The effect of some commercially available antihistamine and decongestant intra-nasal formulations on ciliary beat frequency. J. Clin. Pharm. Ther. 18:1993;219-222.
95. Jian L., Li Wan Po A. Effect of angiotensin-converting enzyme (ACE) inhibitors on ciliary activity. Int. J. Pharm. 107:1994;77-81.
96. Su X.Y., Po A.L.W. Surface-response study of the effect of pH and tonicity on ciliary activity. STP Pharma. Sci. 4:1994;82-85.
97. Pereswetolf-Morath L., Bjurstrom S., Khan R., Dahlin M., Edman P. Toxicological aspects of the use of dextran microspheres and thermogelling ethyl(hydroxyethyl)cellulose (EHEC) as nasal drug delivery systems. Int. J. Pharm. 128:1996;9-21.
98. Saano V., Minker E., Joki S., Virta P., Nuutinen J., Korbonits D. Influence of chinoin-170, a novel antitussive, on the mucociliary activity in respiratory airways of rats, rabbits, guinea-pigs and man. J. Pharm. Pharmacol. 45:1993;799-802.
99. Batts A.H., Marriott C., Martin G.P., Wood C.F., Bond S.W. The effect of some preservatives used in nasal preparations on the mucus and ciliary components of mucociliary clearance. J. Pharm. Pharmacol. 42:1990;145-151.
100. Van de Donk H.J.M., Muller-Plantema I.P., Zuidema J., Merkus F.W.H.M. The effects of preservatives on the ciliary beat frequency of chicken embryo tracheas. Rhinology. 18:1980;119-130.
101. Schipper N.G.M., Verhoef J., Romeijin S.G., Merkus F.W.H.M. Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning. J. Control. Release. 21:1992;173-186.
102. Romeijn S.G., Verhoef J.C., Marttin E., Merkus F.W.H.M. The effect of nasal drug formulations on ciliary beating in vitro. Int. J. Pharm. 135:1996;137-145.
103. Honda N., Saito H., Yamada T., Noda I. Basic study on the effect of nasally administered salmon calcitonin preparation on the nasal ciliary epithelium. Auris Nasus Larynx. 19:1992;115-123.
104. Schlosser R.J., Franco R.A., Czaja J.M., McCaffrey T.V. Modulation of ciliary beat frequency in the upper airway by prostaglandins. Rhinology. 10:1996;229-233.
105. Dolata J., Lindberg S., Mercke U. The effect of prostaglandins E1, E2, and E2α on mucociliary activity in the rabbit maxillary sinus. Acta Otolaryngol. 108:1989;290-297.
106. Kakuta Y., Sasaki H., Takishima T. Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir. Physiol. 83:1991;313-321.
107. Takeyama K., Tamaoki J., Chiyotani A., Tagaya E., Konno K. Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in-vitro. J. Pharm. Pharmacol. 45:1993;759-768.
108. Tamaoki J., Sakai S., Chiyotani A., Takeyama K., Tagaya E., Konno K. Effects of prostacyclin and beraprost on ciliary motility of rabbit airway epithelium. Pharmacology. 48:1994;194-200.
109. Chevillard M., Hinnrasky J., Zahm J.M., Plotkowski M.C., Puchelle E. Proliferation, differentiation and ciliary beating of human respiratory ciliated cells in primary culture. Cell Tissue Res. 264:1991;49-55.
110. Chevillard M., Hinnrasky J., Pierrot D., Zahm J.-M., Klossek J.-M., Puchelle E. Differentiation of human surface upper airway epithelial cells in primary culture on a floating collagen gel. Epithelial Cell Biol. 2:1993;17-25.
111. Rautiainen M., Matsune S., Yoshitsugu M., Ohyama M. Degeneration of human respiratory cell ciliary beat in monolayer cell cultures. Eur. Arch. Otorhinolaryngol. 250:1993;97-100.
112. Yoshitsugu M., Hanamure Y., Furuta S., Deguchi K., Ueno K., Rautiainen M. Ciliary motility and surface morphology of cultured human respiratory epithelial cells during ciliogenesis. Biol. Cell. 82:1994;211-216.
113. De Jong P.M., Van Sterkenburg M.A.J.A., Hesseling S.C., Kempenaar J.A., Mulder A.A., Mommaas A.M., Dijkman J.H., Ponec M. Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface. Am. J. Respir. Cell Mol. Biol. 10:1994;271-277.
114. Cervin A., Lindberg S., Mercke U. Effects of halothane on mucociliary activity in vivo. Otolaryngol. Head Neck Surg. 112:1995;714-722.
115. Cervin A., Lindberg S., Dolata J., Mercke U. Cyclic adenosine monophosphate stimulation of mucociliary activity in the upper airways in vivo. Ann. Otol. Rhinol. Laryngol. 104:1995;388-393.
116. Lindberg S., Runer T. Method for in vivo measurement of mucociliary activity in the human nose. Ann. Otol. Rhinol. Laryngol. 103:1994;558-566.
117. Lindberg S., Runer T., Cervin A., Thomasson L. Recordings of mucociliary activity in vivo: benefit of fast Fourier transformation of the photoelectric signal. Ann. Otol. Rhinol. Laryngol. 105:1996;734-745.
118. King M., Bilboa A., Meyer F.A., Silberberg A. On the transport of mucus and its rheological simulants in ciliated system. Am. Rev. Respir. Dis. 110:1974;740-745.
119. Eliezer N., Sade J., Silberberg A., Nevo A.C. The role of mucus in transport by cilia. Am. Rev. Respir. Dis. 102:1970;48-52.
120. Rubin M.K., Ramirez O., King M. Mucus-depleted frog palate as a model for the study of mucociliary clearance. J. Appl. Physiol. 69:1990;424-429.
121. Dulfano M.J., Adler K.B. Physical properties of sputum. VII. Rheologic properties and mucociliary transport. Am. Rev. Respir. Dis. 112:1975;341-347.
122. Spungin B., Silberberg A. Stimulation of mucus secretion, ciliary activity and transport in frog palate epithelium. Am. J. Physiol. 247:1984;C299-C308.
123. Puchelle E., Petit A., Adnet J.J. Fine structure of the frog palate mucociliary epithelium. J. Submicrosc. Cytol. Pathol. 16:1984;273-282.
124. Giordano A., Shih C.K., Holsclaw D.S., Khan M.A., Litt M. Mucus clearance: in vivo canine tracheal clearance vs. in vitro bullfrog palate studies. J. Appl. Physiol. 42:1977;761-766.
125. Saldiva P.H.N., Parad M.A.C., Macchione M., Paiva P.S.O., Guimaraes E.T., Lorenzi G., Martins M.A., Montes G.S., Balbani A.P., King M. Nasal mucus clearance in rats: differences with sex and phase of the oestrous cycle. J. Appl. Toxicol. 15:1995;289-295.
126. Yu D.M., Amidon G.L., Weiner N.D., Fleisher D., Goldberg A.H. The role of rheological properties in mucociliary transport by frog palate ciliated model. Pharm. Res. 11:1994;1785-1791.
127. Lin S.Y., Amidon G.L., Weiner N.D., Goldberg A.H. Viscoelasticity of cellulose polymers and mucociliary transport on frog palates. Int. J. Pharm. 95:1993;57-65.
128. Lin S.Y., Amidon G.L., Weiner N.D., Goldberg A.H. Viscoelasticity of anionic polymers and their mucociliary transport on the frog palate. Pharm. Res. 10:1993;411-417.
129. Pritchard K., Lansley A.B., Martin G.P., Helliwell M., Marriott C., Benedetti L.M. Evaluation of the bioadhesive properties of hyaluronan derivatives: detachment weight and mucociliary transport rate studies. Int. J. Pharm. 129:1996;137-145.
130. Batts A.H., Marriott C., Martin G.P., Bond S.W. The effect of some preservatives used in nasal preparations on mucociliary clearance. J. Pharm. Pharmacol. 41:1989;156-159.
131. Gizurarson S., Marriott C., Martin G.P., Bechgaard E. The influence of insulin and some excipients used in nasal insulin preparations on mucociliary clearance. Int. J. Pharm. 65:1990;243-247.
132. Bechgaard E., Gizurarson S., Hjortkjær R.K., Sorensen A.R. Intranasal administration of insulin to rabbits using glycofurol as an absorption promoter. Int. J. Pharm. 128:1996;287-289.
133. Aspden T.J., Adier J., Davis S.S., Skaugrud O., Illum L. Chitosan as a nasal delivery system. Evaluation of the effect of chitosan on mucociliary clearance rate in the frog palate model. Int. J. Pharm. 122:1995;69-78.
134. Mason J.D.T., Aspden T.J., Adler J., Jones N.S., Illum L., Davis S.S. Measurement of nasal mucociliary transport rates on the isolated human inferior turbinate. Clin. Otolaryngol. 20:1995;530-535.
135. King M. Relationship between mucus viscoelasticity and ciliary transport in guaran gel/frog palate model system. Biorheology. 17:1980;249-254.
136. Marriott C. The viscoelastic nature of mucus secretion. Chest. 80:1981;804-808.
137. Ingels K., Van Hoorn V., Obrie E., Osmanagaoglu K. A modified technetium-99m isotope test to measure nasal mucociliary transport: comparison with the saccharine-dye test. Eur. Arch. Otorhinolaryngol. 252:1995;340-343.
138. Hardy J.G., Lee S.W., Wilson C.G. Intranasal drug delivery by spray and drops. J. Pharm. Pharmacol. 37:1985;294-297.
139. Batts A.H., Marriott C., Martin G.P., Bond S.W., Greaves J.L., Wilson C.G. The use of a radiolabelled saccharin solution to monitor the effect of the preservatives thiomersal, benzalkonium chloride and EDTA on human nasal clearance. J. Pharm. Pharmacol. 43:1991;180-185.
140. Harris A.S., Nilson I.M., Wagner Z.G., Alkner U. Intranasal administration of peptides: Nasal deposition, biological response, and absorption of desmopressin. J. Pharm. Sci. 75:1986;1085-1088.
141. Illum L., Jorgensen H., Bisgaard H., Krogsgaard O., Rossing N. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm. 39:1987;189-199.
142. Takeuchi K., Sakakura Y., Mural S., Majiina Y. Nasal mucociliary clearance in Sjögrens Syndrome. Acta Otolaryngol. 108:1989;126-129.
143. Sasaki Y., Togo Y., Wagner H.N. Jr., Hornick R.B., Schwartz A.R., Proctor D.F. Mucociliary function during experimentally induced rhinovirus infection in man. Ann. Otol. Rhinol. Laryngol. 82:1973;203-211.
144. Andersen I., Camner P., Jensen P.L., Philipson K., Proctor D.F. Nasal clearance in monozygotic twins. Am. Rev. Respir. Dis. 110:1974;301-305.
145. Simon H., Drettner B., Jung B. Messung des Schiemhauttransportes in menschlichen Nase mit 51Cr markierten Harzküogelchen. Acta Otolaryngol. 83:1977;378-390.
146. Sackner M.A. Mucociliary transport. Ann. Otol. Rhinol. Laryngol. 87:1978;474-483.
147. Yergin B.M., Saketkhoo K., Michaelson E.D., Serafini S.M., Kovitz K., Sackner M.A. A roentgenographic method for measuring nasal mucous velocity. J. Appl. Physiol. 44:1978;964-968.
148. Passali D., Bianchini Ciampoli M. Normal values of mucociliary transport time in young subjects. Int. J. Ped. Otorhinolaryngol. 9:1985;151-156.
149. Outzen K.-E., Svane-Knudsen V. Effect of surface-active substance on nasal mucociliary clearance time before and after the use of surface-active substance. Rhinology. 31:1993;155-157.
150. Puchelle E., Aug F., Pham Q.T., Bertrand A. Comparison of three methods for measuring nasal mucociliary clearance in man. Acta Otolaryngol. 91:1981;297-303.
151. Sakakura Y., Ukai K., Majima Y., Murai S., Harada T., Miyoshi Y. Nasal mucociliary clearance under various conditions. Acta Otolaryngol. 96:1983;167-173.
152. Rutland J., Cole P.J. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax. 36:1981;654-658.
153. Maurizi M., Paludetti G., Ottavianni F., Almadori G., Falcetti S. Mucociliary function and nasal resistance evaluation before and after adenoidectomy. Int. J. Ped. Otorhinolaryngol. 11:1986;295-300.
154. Hady M.R.A., Shehata O., Hassan R. Nasal mucociliary function in different diseases of the nose. J. Laryngol. Otol. 97:1983;497-502.
155. Hohnberg K., Bjork E., Bake B., Edman P. Influence of degradable starch microspheres on the human nasal mucosa. Rhinology. 32:1994;74-77.
156. Duchateau G.S.M.J.E., Graamans K., Zuidema J., Merkus F.W.H.M. Correlation between ciliary beat frequency and mucus transport in volunteers. Laryngoscope. 95:1985;854-859.
157. Karlsson G., Pipkorn U., Andreasson L. Substance P and human nasal mucociliary activity. Eur. J. Clin. Pharmacol. 30:1986;355-357.
158. Passali D., Bellussi L., Bianchini-Ciampoli M., De-Seta E. Experiences in the determination of nasal mucociliary transport time. Acta Otolaryngol. 97:1984;319-323.
159. Takeuchi K., Suzumura E., Majiina Y., Sakakura Y. Effect of atropine on nasal mucociliary clearance. Acta Otolaryngol. 110:1990;120-123.
160. Zhou M., Donovan M. Intranasal mucociliary clearance of putative bioadhesive polymer gels. Int. J. Pharm. 135:1996;115-125.
161. Donovan M.D., Zhou M. Drug effects on in vivo nasal clearance in rats. Int. J. Pharm. 116:1995;77-86.
162. Gatto L.A. Cholinergic and adrenergic stimulation of mucociliary transport in the rat trachea. Respir. Physiol. 92:1993;209-217.
163. Wong L.B., Yeates D.B. Stimulation of tracheal ciliary beat frequency by localized tissue incision. J. Appl. Physiol. 68:1990;411-416.
164. Nakamura M., Yamaya M., Fukushima T., Sekizawa K., Sasaki H., Takishima T. Effect of mabuterol on tracheal mucociliary clearance of magnetized iron particles in anesthetized dogs. Respiration. 58:1991;33-36.
165. Lindberg S., Khan R., Runer T. The effects of formoterol, a long-acting beta(2)-adrenoreceptor agonist, on mucociliary activity. Eur. J. Pharmacol. 285:1995;275-280.
166. Macchione M., King M., Lorenzi-Filho G., Guimaraes E.T., Zin W.A., Böhm G.M., Saldiva P.H.N. Rheological determinants of mucociliary transport in the nose of the rat. Respir. Physiol. 99:1995;165-172.
167. Lucas A.M., Douglas L.C. Principles underlying ciliary activity in the respiratory tract. Arch. Otolaryngol. 20:1934;518-541.
168. Hee J., Guilerm R. Discussion on smoke and mucociliary transport. Eur. J. Respir. Dis. 66:1985;8688.
169. Ukai K., Sakakura Y., Sakai S. Interactions between mucociliary transport and the ciliary beat of chicken nasal mucosa. Arch. Otorhinolaryngol. 242:1985;225-231.
170. Saano V., Virta P., Joki S., Nuutinen J., Karttunen P., Silvasti M. ATP induces respiratory ciliostimulation in rat and guinea pig in vitro and in vivo. Rhinology. 30:1992;33-40.
171. Tamaoki J., Chiyotani A., Sakai S., Takeyama K., Konno K. Effect of azelastine on sulphur dioxide induced impairment of ciliary motility in airway epithelium. Thorax. 48:1993;542-546.
172. Wang J.Q., Bu G.X. Studies of rhinitis medicamentosa. Chin. Med. J. 104:1991;60-63.
173. Hybbinette J.C., Mercke U. Effects of the parasympathomimetic agonists and antagonists on mucociliary activity. Acta Otolaryngol. 93:1982;465-473.
174. Corssen G., Alien C.R. Acetylcholine: its significance in controlling ciliary activity of human respiratory epithelium in vitro. J. Appl. Physiol. 14:1959;901-904.
175. Seybold Z.V., Mariassy A.T., Stroll D., Kiln C.S., Gazeroglu H., Wanner A. Mucociliary interaction in vitro: effects of physiological and inflammatory stimuli. J. Appl. Physiol. 68:1990;1421-1426.
176. Wong L.B., Miller I.F., Yeates D.B. Regulation of ciliary beat frequency by autonomic mechanisms: in vitro. J. Appl. Physiol. 65:1988;1895-1901.
177. Maurer D.R., Sielczak M., Oliver W., Abraham W.M., Wanner A. Role of ciliary motility in acute allergic mucociliary dysfunction. J. Appl. Physiol. 52:1982;1018-1023.
178. Wanner A., Salathe M., O'Riordan T.G. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154:1996;1868-1902.
179. Roberts D.N., Birchall M.A., East C.A., East C.A., Scadding G. Intranasal salbutamol has no effect on mucociliary clearance in normal subjects. Clin. Otolaryngol. 20:1995;246-248.
180. Ingels K.J.A.O., Meeuwsen F., Graamans K., Huizing E.H. Influence of sympathetic and parasympathetic substances in clinical concentrations on human nasal ciliary beat. Rhinology. 30:1992;149-160.
181. Cervin A., Bende M., Lindberg S., Mercke U., Olsson P. Relations between blood flow and mucociliary activity in the rabbit maxillary sinus. Acta Otolaryngol. 105:1988;350-356.
182. Ainge G., Bowles J.A.K., McCormick S.G., Richards D.H., Scales M.D.C. Lack of deleterious effects of corticosteroid sprays containing benzalkonium chloride on nasal ciliated epithelium. In vivo results in laboratory animals. Drug Invest. 8:1994;127-133.
183. Achterrat-Tuckermann U., Saano V., Minker E., Stroman F., Amy O., Joki S., Nuutinen J., Szelenyi I. Influence of azelastine and some selected drugs on mucociliary clearance. Lung. 170:1992;201-209.
184. Pasali D., Piragine F. A comparison of azelastine nasal spray and cetrizine tablets in the treatment of allergic rhinitis. J. Int. Med. Res. 22:1994;17-23.
185. Klimek L., Mosges R. Therapeutic management of mucociliary transport disturbances in allergic rhinitis. Eur. Respir. J. 8:1995;1298.
186. Van de Donk H.J.M., Van Egmond A.L.M., Van den Heuvel A.G.M., Zuidema J., Merkus F.W.H.M. The effects of drugs on ciliary motility, III: local anaesthetics and anti-allergic drugs. Int. J. Pharmacol. 12:1982;77-85.
187. Hermens W.A.J.J., Schüsler-Van Hees M.T.I.W., Merkus F.W.H.M. The in vitro effect of morphine, fentanyl and sufentanil on ciliary beat frequency of human nasal epithelial tissue. Acta Pharm. Technol. 33:1987;88-90.
188. Landa J.F., Hirsch J.A., Lebeaux M.I. Effects of topical and general anesthetics on tracheal mucous velocity in sheep. J. Appl. Physiol. 38:1975;946-948.
189. Forbes A.R., Gamsu G. Mucociliary clearance in canine lung during and after general anesthesia. Anesthesiology. 50:1979;26-29.
190. Lichtiger M., Landa J.F., Hirsch J.A. Velocity of tracheal mucus in anesthetized women undergoing gynecological surgery. Anesthesiology. 42:1975;753-756.
191. Wolff R.K., Allen D.L., Hughes A.B.L., Osier M., Dorato M.A. Nasal clearance in rhesus monkeys. J. Aerosol Med. Deposition Clear. Eff. Lung. 6:1993;111-119.
192. Illum L. Nasal delivery. The use of animal models to predict performance in man. J. Drug Targeting. 3:1996;427-442.
193. Braga P.C., Allegra L., Rampdoli C., Beghi G., Ornaghi A., Caminiti G., Zheng Y.R., Bartucci F. Topical tolerability of salmon calcitonin assessed by mucociliary transport velocity investigation. Drug Res. 40:1990;938-941.
194. Berg O.H., Lie K., Steinsvåg S.K. The effect of decongestive nosedrops on human respiratory mucosa in vitro. Laryngoscope. 104:1994;1153-1158.
195. Van De Donk H.J.M., Van Den Heuvel A.G.M., Merkus F.W.H.M. The effects of nasal drops and their additives on human nasal mucociliary clearance. Rhinology. 20:1982;127-137.
196. Braat J.P.M., Ainge G., Bowles J.A.K., Richards D.H., Van Riesen D., Visser W.J., Rijntjes E. The lack of effect of benzalkonium chloride on the cilia of the nasal mucosa in patients with perennial allergic rhinitis: a combined functional, light, scanning and transmission electron microscopy. Clin. Exp. Allergy. 25:1995;957-965.
197. Scadding G.K. Rhinitis medicamentosa. Clin. Exp. Allergy. 25:1995;391-394.
198. Mygind N., Thomsen J., Jorgensen M.B. Ultrastructure of the epithelium in atrophic rhinitis. Acta Otolaryngol. 77:1974;439-446.
199. Graf P., Hallen H., Juto J.E. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin. Exp. Allergy. 25:1995;395-400.
200. Hallen H., Graf P. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Clin. Exp. Allergy. 25:1995;401-405.
201. Talaat M., Belal A., Aziz T., Mandour M., Maher A. Rhinitis medicamentosa: electron microscopic study. J. Laryngol. Otol. 95:1981;125-131.
202. Graf P., Hallen H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope. 106:1996;605-609.
203. Hirai S., Yahiki T., Mima H. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9:1981;173-184.
204. Pontiroli A.E., Alberetto M., Secchi A., Dossi G., Bosi I., Pozza G. Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. Br. Med. J. 284:1982;303-306.
205. Duchateau G.S.M.J.E., Zuidema J., Merkus F.W.H.M. Bile salts and nasal drug absorption. Int. J. Pharm. 31:1986;193-199.
206. Longenecker J.P., Moses A.C., Flier J.S., Silver R.D., Carey M.C., Dubovi E.J. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J. Pharm. Sci. 76:1987;351-355.
207. Hersey S.J., Jackson R.T. Effect of bile salts on nasal permeability in vitro. J. Pharm. Sci. 76:1987;876-879.
208. Donovan M.D., Flynn G.L., Amidon G.L. The molecular weight dependence of nasal absorption: the effect of absorption enhancers. Pharm. Res. 7:1990;808-815.
209. Chandler S.G., Illum L., Thomas N.W. Nasal absorption in the rat. 1: A method to demonstrate the histological effects of nasal formulations. Int. J. Pharm. 70:1991;19-27.
210. Chandler S.G., Illum L., Thomas N.W. Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology. Int. J. Pharm. 76:1991;61-70.
211. Marttin E., Verhoef J.C., Romeijn S.G., Zwart P., Merkus F.W.H.M. Acute histopathological effects of benzalkonium chloride and absorption enhancers on rat nasal epithelium in vivo. Int. J. Pharm. 141:1996;151-160.
212. Pontiroli A.E., Alberetto M., Calderara A., Pajetta E., Pozza G. Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents. Eur. J. Clin. Pharmacol. 37:1989;427-430.
213. Pontiroli A.E., Pajetta E., Calderara A., Alberetto M., Pozza G., Manganelli V., Resmini G., Tessari L., Maresca V. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study. J. Endocrinol. Invest. 14:1991;47-51.
214. Kissel T., Drewe J., Bantle S., Rummelt A., Beglinger C. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy volunteers. Pharm. Res. 9:1992;52-57.
215. Hermens W.A.J.J., Deurloo M.J.M., Romeijn S.G., Verhoef J.C., Merkus F.W.H.M. Nasal absorption enhancement of 17-β-oestradiol by dimethyl-β-cyclodextrin in rabbits and rats. Pharm. Res. 7:1990;500-503.
216. Schipper N.G.M., Hermens W.A.J.J., Romeijn S.G., Verhoef J., Merkus F.W.H.M. Nasal absorption of 17-β-oestradiol and progesterone from a dimethyl-β-cyclodextrin inclusion formulation in rats. Int. J. Pharm. 64:1990;61-66.
217. Verhoef J.C., Schipper N.G., Romeijn S.G., Merkus F.W.H.M. The potential of cyclodextrins as absorption enhancers in nasal delivery of peptide drugs. J. Control. Release. 29:1994;351-360.
218. Schipper N.G.M., Romeijn S.G., Verhoef J.C., Merkus F.W.H.M. Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations. Pharm. Res. 10:1993;682-686.
219. Schipper N.G.M., Verhoef J.C., Romeijn S.G., Merkus F.W.H.M. Methylated β-cyclodextrins are able to improve the nasal absorption of salmon calcitonin. Calcif. Tissue Int. 56:1995;280-282.
220. Matsubara K., Abe K., Irie T., Uekama K. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats. J. Pharm. Sci. 84:1995;1295-1300.
221. Merkus F.W.H.M., Schipper N.G.M., Hermens W.A.J.J., Romeijn S.G., Verhoef J.C. Absorption enhancers in nasal drug delivery: efficacy and safety. J. Control. Release. 24:1993;201-208.
222. Hermens W.A.J.J., Belder C.W.J., Merkus J.M.W.M., Hooymans P.M., Verhoef J., Merkus F.W.H.M. Intranasal estradiol administration to oophorectomized women. Eur. J. Obstet. Gynecol. Reprod. Biol. 40:1991;35-41.
223. Merkus F.W.H.M., Schipper N.G.M., Verhoef J.C. The influence of absorption enhancers on the intranasal insulin absorption in normal and diabetic subjects. J. Control. Release. 41:1996;69-75.
224. Rusznak C., Devalia J.L., Lozewicz S., Davies R.J. The assessment of nasal mucociliary clearance and the effect of drugs. Respir. Med. 88:1994;89-101.
225. Su X.Y., Mettern C., Håcker R., Li Wan Po A. Does sea water made isotonic affect ciliary beat frequency? Int. J. Pharm. 123:1995;47-51.
226. Garay R.P. Azelastine: well known ciliotoxic agent? Int. J. Pharm. 136:1996;181-183.
227. Ennis R.D., Borden L., Lee W.A. The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: A scanning electron microscopy study. Pharm. Res. 7:1990;468-475.
228. Marttin E., Verhoef J.C., Romeijn S.G., Merkus F.W.H.M. Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity. Pharm. Res. 12:1995;1151-1157.
229. Gizurarson S. Animal models for intranasal drug delivery studies. Acta Pharm. Nord. 2:1990;105-122.
230. Aoki F.Y., Crawley J.C.W. Distribution and removal of human serum albumin-technetium-99m instilled intranasally. Br. J. Clin. Pharmacol. 3:1976;869-878.
231. Parr G.D. Nasal delivery of drugs. Pharm. Int. 4:1983;202-205.
232. Quinlan M.F., Salman S.D., Swift D.L., Wagner H.N. Jr., Proctor D.F. Measurement of mucociliary function in man. Am. Rev. Respir. Dis. 99:1969;13-23.
233. Marttin E., Romeijn S.G., Verhoef J.C., Merkus F.W.H.M. Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits. J. Pharm. Sci. 86:1997;802-807.
234. Gonda I., Gipps E. Model of disposition of drugs administered into the human nasal cavity. Pharm. Res. 7:1990;69-75.
235. Harris A.S., Svensson E., Wagner Z.G., Lethagen S., Nilsson I.M. Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin. J. Pharm. Sci. 77:1988;405-408.
236. Harris A.S., Olin M., Svensson E., Lethagen S., Nilsson I.M. Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin. J. Pharm. Sci. 78:1989;470-471.
237. Pennington A.K., Ratcliffe J.H., Wilson C.G., Hardy J.G. The influence of solution viscosity on nasal spray deposition and clearance. Int. J. Pharm. 43:1988;221-224.
238. T. Nagai, Y. Machida, Bioadhesive dosage forms for nasal administration, in: V. Lenaerts, R. Gumy (Eds.), Bioadhesive Drug Delivery Systems, CRC Press, Boca Raton, FL, 1990, pp. 169-178.
239. Nagai T., Nishimoto Y., Nambu N., Suzuki Y., Sekine K. Powder dosage form of insulin for nasal administration. J. Control. Release. 1:1984;15-22.
240. Nakamura F., Ohta R., Machida Y., Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int. J. Pharm. 134:1996;173-181.
241. Illum L., Farraj N., Critchley H., Davis S.S. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 46:1988;261-265.
242. Bjork E., Edman P. Characterization of degradable starch microspheres as a nasal delivery system. Int. J. Pharm. 62:1990;187-192.
243. Farraj N.F., Johansen B.R., Davis S.S., Illum L. Nasal administration of insulin using bioadhesive microspheres as a nasal delivery system. J. Control. Release. 13:1990;253-261.
244. Illum L., Farraj N.F., Fisher A.N., Gill I., Miglietta M., Benedetti L.M. Hyaluronic acid ester microspheres as a nasal delivery system for insulin. J. Control. Release. 29:1994;133-141.
245. Critchley H., Davis S.S., Farraj N.F., Illum L. Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. J. Pharm. Pharmacol. 46:1994;651-656.
246. Edman P., Björk E., Ryden L. Microspheres as a nasal delivery system for peptide drugs. J Control. Release. 21:1992;165-172.
247. Ridley D., Perkins A.C., Washington N., Wilson C.G., Wastie M.L., O'Flynn P., Blattinan A., Ponchel G., Duchene D. The effect of posture on nasal clearance of bioadhesive starch microspheres. STP Pharma. Sci. 5:1995;442-446.
248. Bjork E., Isaksson U., Edman P., Artursson P. Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. J. Drug Targeting. 2:1995;501-507.
249. Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1994;1186-1189.
250. Aspden T.J., Illum L., Skaugrud O. Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 4:1996;2331.
251. Cervin A., Lindberg S., Mercke U. The effect of noradrenaline on mucociliary activity in the rabbit maxillary sinus. Rhinology. 31:1993;17-21.
252. Dudley J.P., Cherry J.D. Effect of topical anesthetics on ciliary activity of chicken embryo tracheal organ cultures. Study using total immersion and intratracheal injection. Ann. Otol. Rhinol. Laryngol. 87:1978;533-537.
253. 2: Effects on morphology and ciliary beating. Toxicol. Vitro. 9:1995;123-132.
254. Braga P.C., Dal Sasso M.D., Bernini A. The effects of calcitonin nasal preparations and their excipients on mucociliary clearance in an ex-vivo frog palate test. J. Pharm. Pharmacol. 44:1992;938-940.